Skip to content
SIIS — Servicio de Información e Investigación Social. Fundación Eguía-Careaga Fundazioa
Está en:
  • Inicio>
  • Centro de documentación>
  • Catálogo bibliográfico
Hemen zaude:
  • Hasiera>
  • Dokumentazio zentroa>
  • Katalogo bibliografikoa
You are here:
  • Home>
  • Documentation centre>
  • Library catalogue
VuFind
  • Login
    • Bootstrap
    • Siis
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
    • Māori
Advanced
  • DO A9 TETRAHYDROCANNABINOL CON...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

DO A9 TETRAHYDROCANNABINOL CONCENTRATIONS INDICATE RECENT USE IN CHRONIC CANNABIS USERS?

Saved in:
KARSCHNER, E.L., ET AL., DO A9 TETRAHYDROCANNABINOL CONCENTRATIONS INDICATE RECENT USE IN CHRONIC CANNABIS USERS?. ADDICTION, Vol. 104, no. 12 (2009), p. 2041-2048.
Ref. 164323
Location: SIIS R.696 Archivo
Solicitar documento
Palabras clave:
Análisis clínicos, Cannabis, Detección, Drogas ilegales, Drogodependencias, Tests
  • Description
  • Comments
  • Similar Items
Description
ISSN:0965-2140 (papel)
1360-0443 (online)

Similar Items

  • DRIVING UNDER THE INFLUENCE OF CANNABIS: A 10 YEAR STUDY OF AGE AND GENDER DIFFERENCES IN THE CONCENTRATIONS OF TETRAHYDROCANNABINOL IN BLOOD
    by: JONES, A.W
  • EXTENDED URINARY A9-TETRAHYDROCANNABINOL EXCRETION IN CHRONIC CANNABIS USERS PRECLUDES USE AS A BIORMARKER OF NEW DRUG EXPOSURE
    by: LOWE, R.H
  • Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial
    by: Hjorthøj, C.R
  • DIFFERENTIATING NEW CANNABIS USE FROM RESIDUAL URINARY CANNABINOID EXCRETION IN CHRONI, DAILY CANNABIS USERS
    by: SCHWILKE, E.W
  • Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15
    by: Niesink, R.J.M

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs